RET and thyroid gland carcinoma: MEN2 is classified based on clinical features in MEN2A characterized by thyroid cancer, pheochromocytoma, and hyperparathyroidism and in MEN2B with also ganglioneuromatosis and a Marfanoid habitus [17].